[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Colorectal Cancer Diagnostic Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 139 pages | ID: G78AFBAB606GEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Fecal occult blood tests dominated the industry in 2016 owing to cost effectiveness and non-invasiveness as compared to colonoscopy and sigmoidoscopy. Immuno-FOB agglutination and Immuno-FOB ELISA tests are major revenue generating segments of fecal occult blood tests segment. Growing awareness along with rising demand for non-invasive cancer screening tests will further fuel business growth.

SCOPE OF THE REPORT:

Increasing incidences of colorectal cancer coupled with rising demand for non-invasive cancer screening tests will drive in-vitro colorectal cancer screening tests market over the forecast period. Growing geriatric population base, highly susceptible to suffer from colorectal cancer will further propel market growth.
The global Colorectal Cancer Diagnostic market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Colorectal Cancer Diagnostic.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Colorectal Cancer Diagnostic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Colorectal Cancer Diagnostic market by product type and applications/end industries.
Market Segment by Companies, this report covers
  • Abbott Molecular
  • Alere
  • Beckman Coulter
  • Eiken Chemical
  • Epigenomics
  • Sysmex
  • Siemens Healthcare
  • Quest Diagnostics
  • CompanianDx
  • BioTime
  • Merck Millipore
  • GeneNews
  • BioMarCare
  • Immunostics
  • ExiQon
  • Mode Diagnostics
  • Randox
  • R-Biopharm
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Fecal Occult Blood Test
  • Biomarker Test
  • CRC DNA Screening Test
Market Segment by Applications, can be divided into
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
1 COLORECTAL CANCER DIAGNOSTIC MARKET OVERVIEW

1.1 Product Overview and Scope of Colorectal Cancer Diagnostic
1.2 Classification of Colorectal Cancer Diagnostic by Types
  1.2.1 Global Colorectal Cancer Diagnostic Revenue Comparison by Types (2017-2023)
  1.2.2 Global Colorectal Cancer Diagnostic Revenue Market Share by Types in 2017
  1.2.3 Fecal Occult Blood Test
  1.2.4 Biomarker Test
  1.2.5 CRC DNA Screening Test
1.3 Global Colorectal Cancer Diagnostic Market by Application
  1.3.1 Global Colorectal Cancer Diagnostic Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
  1.3.4 Diagnostic Centers
1.4 Global Colorectal Cancer Diagnostic Market by Regions
  1.4.1 Global Colorectal Cancer Diagnostic Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Colorectal Cancer Diagnostic Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Colorectal Cancer Diagnostic Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Colorectal Cancer Diagnostic Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Colorectal Cancer Diagnostic Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Colorectal Cancer Diagnostic Status and Prospect (2013-2023)
1.5 Global Market Size of Colorectal Cancer Diagnostic (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Abbott Molecular
  2.1.1 Business Overview
  2.1.2 Colorectal Cancer Diagnostic Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Abbott Molecular Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.2 Alere
  2.2.1 Business Overview
  2.2.2 Colorectal Cancer Diagnostic Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Alere Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.3 Beckman Coulter
  2.3.1 Business Overview
  2.3.2 Colorectal Cancer Diagnostic Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Beckman Coulter Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eiken Chemical
  2.4.1 Business Overview
  2.4.2 Colorectal Cancer Diagnostic Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Eiken Chemical Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.5 Epigenomics
  2.5.1 Business Overview
  2.5.2 Colorectal Cancer Diagnostic Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Epigenomics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sysmex
  2.6.1 Business Overview
  2.6.2 Colorectal Cancer Diagnostic Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Sysmex Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.7 Siemens Healthcare
  2.7.1 Business Overview
  2.7.2 Colorectal Cancer Diagnostic Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Siemens Healthcare Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.8 Quest Diagnostics
  2.8.1 Business Overview
  2.8.2 Colorectal Cancer Diagnostic Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Quest Diagnostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.9 CompanianDx
  2.9.1 Business Overview
  2.9.2 Colorectal Cancer Diagnostic Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 CompanianDx Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.10 BioTime
  2.10.1 Business Overview
  2.10.2 Colorectal Cancer Diagnostic Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 BioTime Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.11 Merck Millipore
  2.11.1 Business Overview
  2.11.2 Colorectal Cancer Diagnostic Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Merck Millipore Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.12 GeneNews
  2.12.1 Business Overview
  2.12.2 Colorectal Cancer Diagnostic Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 GeneNews Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.13 BioMarCare
  2.13.1 Business Overview
  2.13.2 Colorectal Cancer Diagnostic Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 BioMarCare Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.14 Immunostics
  2.14.1 Business Overview
  2.14.2 Colorectal Cancer Diagnostic Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 Immunostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.15 ExiQon
  2.15.1 Business Overview
  2.15.2 Colorectal Cancer Diagnostic Type and Applications
    2.15.2.1 Product A
    2.15.2.2 Product B
  2.15.3 ExiQon Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.16 Mode Diagnostics
  2.16.1 Business Overview
  2.16.2 Colorectal Cancer Diagnostic Type and Applications
    2.16.2.1 Product A
    2.16.2.2 Product B
  2.16.3 Mode Diagnostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.17 Randox
  2.17.1 Business Overview
  2.17.2 Colorectal Cancer Diagnostic Type and Applications
    2.17.2.1 Product A
    2.17.2.2 Product B
  2.17.3 Randox Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.18 R-Biopharm
  2.18.1 Business Overview
  2.18.2 Colorectal Cancer Diagnostic Type and Applications
    2.18.2.1 Product A
    2.18.2.2 Product B
  2.18.3 R-Biopharm Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL COLORECTAL CANCER DIAGNOSTIC MARKET COMPETITION, BY PLAYERS

3.1 Global Colorectal Cancer Diagnostic Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Colorectal Cancer Diagnostic Players Market Share
  3.2.2 Top 10 Colorectal Cancer Diagnostic Players Market Share
3.3 Market Competition Trend

4 GLOBAL COLORECTAL CANCER DIAGNOSTIC MARKET SIZE BY REGIONS

4.1 Global Colorectal Cancer Diagnostic Revenue and Market Share by Regions
4.2 North America Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
4.3 Europe Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
4.5 South America Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA COLORECTAL CANCER DIAGNOSTIC REVENUE BY COUNTRIES

5.1 North America Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)
5.2 USA Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
5.3 Canada Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
5.4 Mexico Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

6 EUROPE COLORECTAL CANCER DIAGNOSTIC REVENUE BY COUNTRIES

6.1 Europe Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)
6.2 Germany Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
6.3 UK Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
6.4 France Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
6.5 Russia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
6.6 Italy Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTIC REVENUE BY COUNTRIES

7.1 Asia-Pacific Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)
7.2 China Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
7.3 Japan Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
7.4 Korea Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
7.5 India Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA COLORECTAL CANCER DIAGNOSTIC REVENUE BY COUNTRIES

8.1 South America Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)
8.2 Brazil Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
8.3 Argentina Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
8.4 Colombia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE COLORECTAL CANCER DIAGNOSTIC BY COUNTRIES

9.1 Middle East and Africa Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)
9.2 Saudi Arabia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
9.3 UAE Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
9.4 Egypt Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
9.5 Nigeria Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
9.6 South Africa Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)

10 GLOBAL COLORECTAL CANCER DIAGNOSTIC MARKET SEGMENT BY TYPE

10.1 Global Colorectal Cancer Diagnostic Revenue and Market Share by Type (2013-2018)
10.2 Global Colorectal Cancer Diagnostic Market Forecast by Type (2018-2023)
10.3 Fecal Occult Blood Test Revenue Growth Rate (2013-2023)
10.4 Biomarker Test Revenue Growth Rate (2013-2023)
10.5 CRC DNA Screening Test Revenue Growth Rate (2013-2023)

11 GLOBAL COLORECTAL CANCER DIAGNOSTIC MARKET SEGMENT BY APPLICATION

11.1 Global Colorectal Cancer Diagnostic Revenue Market Share by Application (2013-2018)
11.2 Colorectal Cancer Diagnostic Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)

12 GLOBAL COLORECTAL CANCER DIAGNOSTIC MARKET SIZE FORECAST (2018-2023)

12.1 Global Colorectal Cancer Diagnostic Market Size Forecast (2018-2023)
12.2 Global Colorectal Cancer Diagnostic Market Forecast by Regions (2018-2023)
12.3 North America Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)
12.4 Europe Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)
12.6 South America Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source



LIST OF TABLES AND FIGURES

Figure Colorectal Cancer Diagnostic Picture
Table Product Specifications of Colorectal Cancer Diagnostic
Table Global Colorectal Cancer Diagnostic and Revenue (Million USD) Market Split by Product Type
Figure Global Colorectal Cancer Diagnostic Revenue Market Share by Types in 2017
Figure Fecal Occult Blood Test Picture
Figure Biomarker Test Picture
Figure CRC DNA Screening Test Picture
Table Global Colorectal Cancer Diagnostic Revenue (Million USD) by Application (2013-2023)
Figure Colorectal Cancer Diagnostic Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Diagnostic Centers Picture
Table Global Market Colorectal Cancer Diagnostic Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbott Molecular Basic Information, Manufacturing Base and Competitors
Table Abbott Molecular Colorectal Cancer Diagnostic Type and Applications
Table Abbott Molecular Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Alere Basic Information, Manufacturing Base and Competitors
Table Alere Colorectal Cancer Diagnostic Type and Applications
Table Alere Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table Beckman Coulter Colorectal Cancer Diagnostic Type and Applications
Table Beckman Coulter Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Eiken Chemical Basic Information, Manufacturing Base and Competitors
Table Eiken Chemical Colorectal Cancer Diagnostic Type and Applications
Table Eiken Chemical Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Epigenomics Basic Information, Manufacturing Base and Competitors
Table Epigenomics Colorectal Cancer Diagnostic Type and Applications
Table Epigenomics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Sysmex Basic Information, Manufacturing Base and Competitors
Table Sysmex Colorectal Cancer Diagnostic Type and Applications
Table Sysmex Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare Colorectal Cancer Diagnostic Type and Applications
Table Siemens Healthcare Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table Quest Diagnostics Colorectal Cancer Diagnostic Type and Applications
Table Quest Diagnostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table CompanianDx Basic Information, Manufacturing Base and Competitors
Table CompanianDx Colorectal Cancer Diagnostic Type and Applications
Table CompanianDx Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table BioTime Basic Information, Manufacturing Base and Competitors
Table BioTime Colorectal Cancer Diagnostic Type and Applications
Table BioTime Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Millipore Basic Information, Manufacturing Base and Competitors
Table Merck Millipore Colorectal Cancer Diagnostic Type and Applications
Table Merck Millipore Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table GeneNews Basic Information, Manufacturing Base and Competitors
Table GeneNews Colorectal Cancer Diagnostic Type and Applications
Table GeneNews Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table BioMarCare Basic Information, Manufacturing Base and Competitors
Table BioMarCare Colorectal Cancer Diagnostic Type and Applications
Table BioMarCare Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Immunostics Basic Information, Manufacturing Base and Competitors
Table Immunostics Colorectal Cancer Diagnostic Type and Applications
Table Immunostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table ExiQon Basic Information, Manufacturing Base and Competitors
Table ExiQon Colorectal Cancer Diagnostic Type and Applications
Table ExiQon Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Mode Diagnostics Basic Information, Manufacturing Base and Competitors
Table Mode Diagnostics Colorectal Cancer Diagnostic Type and Applications
Table Mode Diagnostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Randox Basic Information, Manufacturing Base and Competitors
Table Randox Colorectal Cancer Diagnostic Type and Applications
Table Randox Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table R-Biopharm Basic Information, Manufacturing Base and Competitors
Table R-Biopharm Colorectal Cancer Diagnostic Type and Applications
Table R-Biopharm Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
Table Global Colorectal Cancer Diagnostic Revenue (Million USD) by Players (2013-2018)
Table Global Colorectal Cancer Diagnostic Revenue Share by Players (2013-2018)
Figure Global Colorectal Cancer Diagnostic Revenue Share by Players in 2016
Figure Global Colorectal Cancer Diagnostic Revenue Share by Players in 2017
Figure Global Top 5 Players Colorectal Cancer Diagnostic Revenue Market Share in 2017
Figure Global Top 10 Players Colorectal Cancer Diagnostic Revenue Market Share in 2017
Figure Global Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Colorectal Cancer Diagnostic Revenue (Million USD) by Regions (2013-2018)
Table Global Colorectal Cancer Diagnostic Revenue Market Share by Regions (2013-2018)
Figure Global Colorectal Cancer Diagnostic Revenue Market Share by Regions (2013-2018)
Figure Global Colorectal Cancer Diagnostic Revenue Market Share by Regions in 2017
Figure North America Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Europe Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure South America Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Table North America Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)
Table North America Colorectal Cancer Diagnostic Revenue Market Share by Countries (2013-2018)
Figure North America Colorectal Cancer Diagnostic Revenue Market Share by Countries (2013-2018)
Figure North America Colorectal Cancer Diagnostic Revenue Market Share by Countries in 2017
Figure USA Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Canada Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Mexico Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Table Europe Colorectal Cancer Diagnostic Revenue (Million USD) by Countries (2013-2018)
Figure Europe Colorectal Cancer Diagnostic Revenue Market Share by Countries (2013-2018)
Figure Europe Colorectal Cancer Diagnostic Revenue Market Share by Countries in 2017
Figure Germany Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure UK Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure France Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Russia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Italy Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Colorectal Cancer Diagnostic Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Colorectal Cancer Diagnostic Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Colorectal Cancer Diagnostic Revenue Market Share by Countries in 2017
Figure China Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Japan Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Korea Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure India Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Table South America Colorectal Cancer Diagnostic Revenue by Countries (2013-2018)
Table South America Colorectal Cancer Diagnostic Revenue Market Share by Countries (2013-2018)
Figure South America Colorectal Cancer Diagnostic Revenue Market Share by Countries (2013-2018)
Figure South America Colorectal Cancer Diagnostic Revenue Market Share by Countries in 2017
Figure Brazil Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Argentina Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Colombia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Colorectal Cancer Diagnostic Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Colorectal Cancer Diagnostic Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Colorectal Cancer Diagnostic Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Colorectal Cancer Diagnostic Revenue Market Share by Countries in 2017
Figure Saudi Arabia Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure UAE Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Egypt Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure Nigeria Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Figure South Africa Colorectal Cancer Diagnostic Revenue and Growth Rate (2013-2018)
Table Global Colorectal Cancer Diagnostic Revenue (Million USD) by Type (2013-2018)
Table Global Colorectal Cancer Diagnostic Revenue Share by Type (2013-2018)
Figure Global Colorectal Cancer Diagnostic Revenue Share by Type (2013-2018)
Figure Global Colorectal Cancer Diagnostic Revenue Share by Type in 2017
Table Global Colorectal Cancer Diagnostic Revenue Forecast by Type (2018-2023)
Figure Global Colorectal Cancer Diagnostic Market Share Forecast by Type (2018-2023)
Figure Global Fecal Occult Blood Test Revenue Growth Rate (2013-2018)
Figure Global Biomarker Test Revenue Growth Rate (2013-2018)
Figure Global CRC DNA Screening Test Revenue Growth Rate (2013-2018)
Table Global Colorectal Cancer Diagnostic Revenue by Application (2013-2018)
Table Global Colorectal Cancer Diagnostic Revenue Share by Application (2013-2018)
Figure Global Colorectal Cancer Diagnostic Revenue Share by Application (2013-2018)
Figure Global Colorectal Cancer Diagnostic Revenue Share by Application in 2017
Table Global Colorectal Cancer Diagnostic Revenue Forecast by Application (2018-2023)
Figure Global Colorectal Cancer Diagnostic Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)
Figure Global Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Colorectal Cancer Diagnostic Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Colorectal Cancer Diagnostic Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)
Figure Europe Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)
Figure South America Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Colorectal Cancer Diagnostic Revenue Market Forecast (2018-2023)


More Publications